New cognitive rehab program aims to clear mental fog after mild brain injury

NCT ID NCT06859996

Recruiting now Symptom relief Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a structured cognitive rehabilitation program (On-TRACC) helps adults with lasting memory, attention, and thinking problems after a mild traumatic brain injury or concussion. Participants will receive six telehealth sessions of either On-TRACC or a general brain-health education program. The goal is to see which approach better reduces cognitive symptoms and improves quality of life over several months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (cognitive rehabilitation vs. psychoeducation)
What this could lead to: If On-TRACC proves better than basic education, it could become a standard, brief therapy for persistent cognitive problems after mild TBI.
What could go wrong: This is a mid-sized trial comparing two talk-based programs, not a drug or device. The difference between them may be small, and results may not apply to all types of brain injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD TRAUMATIC BRAIN INJURY, CONCUSSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Concussion traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MILD TRAUMATIC BRAIN INJURY, CONCUSSION

Contacts and locations

Locations

University of Washington
RECRUITING

Seattle, Washington, 98195, United States
VA Puget Sound Health Care System
RECRUITING

Seattle, Washington, 98108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.